Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation
- PMID: 28767701
- PMCID: PMC5540275
- DOI: 10.1371/journal.pone.0181282
Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation
Abstract
Objectives: Increased expression of adenylyl cyclase type 6 (AC6) has beneficial effects on the heart through cyclic adenosine monophosphate (cAMP)-dependent and cAMP-independent pathways. We previously generated a catalytically inactive mutant of AC6 (AC6mut) that has an attenuated response to β-adrenergic receptor stimulation, and, consequently, exhibits reduced myocardial cAMP generation. In the current study we test the hypothesis that cardiac-directed expression of AC6mut would protect the heart from sustained β-adrenergic receptor stimulation, a condition frequently encountered in patients with heart failure.
Methods and results: AC6mut mice and transgene negative siblings received osmotic mini-pumps to provide continuous isoproterenol infusion for seven days. Isoproterenol infusion caused deleterious effects that were attenuated by cardiac-directed AC6mut expression. Both groups showed reduced left ventricular (LV) ejection fraction, but the reduction was less in AC6mut mice (p = 0.047). In addition, AC6mut mice showed superior left ventricular function, manifested by higher values for LV peak +dP/dt (p = 0.03), LV peak -dP/dt (p = 0.008), end-systolic pressure-volume relationship (p = 0.003) and cardiac output (p<0.03). LV samples of AC6mut mice had more sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) protein (p<0.01), which likely contributed to better LV function. AC6mut mice had lower rates of cardiac myocyte apoptosis (p = 0.016), reduced caspase 3/7 activity (p = 0.012) and increased B-cell lymphoma 2 (Bcl2) expression (p = 0.0001).
Conclusion: Mice with cardiac-directed AC6mut expression weathered the deleterious effects of continuous isoproterenol infusion better than control mice, indicating cardiac protection.
Conflict of interest statement
Figures





Similar articles
-
Preserved cardiac function despite marked impairment of cAMP generation.PLoS One. 2013 Sep 16;8(9):e72151. doi: 10.1371/journal.pone.0072151. eCollection 2013. PLoS One. 2013. PMID: 24147149 Free PMC article.
-
Adenylyl cyclase 6 improves calcium uptake and left ventricular function in aged hearts.J Am Coll Cardiol. 2011 May 3;57(18):1846-55. doi: 10.1016/j.jacc.2010.11.052. J Am Coll Cardiol. 2011. PMID: 21527160 Free PMC article.
-
Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant.Mol Pharmacol. 2011 Mar;79(3):381-8. doi: 10.1124/mol.110.067298. Epub 2010 Dec 2. Mol Pharmacol. 2011. PMID: 21127130 Free PMC article.
-
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.Heart Fail Rev. 2010 Sep;15(5):495-512. doi: 10.1007/s10741-010-9183-5. Heart Fail Rev. 2010. PMID: 20658186 Free PMC article. Review.
-
New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.J Pharmacol Sci. 2009 Mar;109(3):354-9. doi: 10.1254/jphs.08r26fm. Epub 2009 Mar 7. J Pharmacol Sci. 2009. PMID: 19270422 Review.
Cited by
-
Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.Physiol Rev. 2025 Apr 1;105(2):541-591. doi: 10.1152/physrev.00013.2024. Epub 2024 Aug 8. Physiol Rev. 2025. PMID: 39115424 Free PMC article. Review.
-
Adenylyl cyclases and TRPV4 mediate Ca2+/cAMP dynamics to enhance fluid flow-induced osteogenesis in osteocytes.J Mol Biochem. 2018;7:48-59. J Mol Biochem. 2018. PMID: 31123666 Free PMC article.
-
Epac1 increases myosin regulatory light-chain phosphorylation, energetic cost of contraction, and susceptibility to heart failure.PLoS One. 2025 Jun 17;20(6):e0325986. doi: 10.1371/journal.pone.0325986. eCollection 2025. PLoS One. 2025. PMID: 40526593 Free PMC article.
-
Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.Physiol Rev. 2022 Apr 1;102(2):815-857. doi: 10.1152/physrev.00013.2021. Epub 2021 Oct 26. Physiol Rev. 2022. PMID: 34698552 Free PMC article. Review.
-
Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles.Front Pharmacol. 2024 Apr 3;15:1370506. doi: 10.3389/fphar.2024.1370506. eCollection 2024. Front Pharmacol. 2024. PMID: 38633617 Free PMC article. Review.
References
-
- Gao MH, Tang T, Guo T, Sun SQ, Feramisco JR, Hammond HK. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem. 2004;279: 38797–3802. doi: 10.1074/jbc.M405701200 - DOI - PubMed
-
- Gao MH, Tang T, Guo T, Yajima T, Pestonjamasp K, Feramisco JR, et al. Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem. 2008;283: 33527–33535. doi: 10.1074/jbc.M805825200 - DOI - PMC - PubMed
-
- Gao MH, Tang T, Lai NC, Miyanohara A, Guo T, Tang R, et al. Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant. Mol Pharmacol. 2011;79: 381–388. doi: 10.1124/mol.110.067298 - DOI - PMC - PubMed
-
- Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, et al. (2008) Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation. 2008;117:61–69. doi: 10.1161/CIRCULATIONAHA.107.730069 - DOI - PubMed
-
- Gao MH, Lai NC, Tang T, Guo T, Tang R, Chun BJ, et al. Preserved cardiac function despite marked impairment of cAMP generation. PLoS One. 2013;8:e72151 doi: 10.1371/journal.pone.0072151 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous